Haley B. Naik

Haley B. Naik

Dermatology

1701 Divisadero St.
Third And Fourth Floors
San Francisco, CA 94115

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 124 publications

GLP-1 Receptor Agonists in Hidradenitis Suppurativa-Emerging Opportunities for Comorbidity Management?

GLP-1 Receptor Agonists in Hidradenitis Suppurativa-Emerging Opportunities for Comorbidity Management?

Journal: JAMA dermatology

Published: July 01, 2026

Acne treated with tumor necrosis factor inhibitors.

Acne treated with tumor necrosis factor inhibitors.

Journal: JAAD international

Published: June 08, 2026

Socioeconomic factors and time to diagnosis in hidradenitis suppurativa.

Socioeconomic factors and time to diagnosis in hidradenitis suppurativa.

Journal: Skin health and disease

Published: May 15, 2026

Computational discovery of precision therapeutics for hidradenitis suppurativa.

Computational discovery of precision therapeutics for hidradenitis suppurativa.

Journal: bioRxiv : the preprint server for biology

Published: March 09, 2026

Health System Experiences and Care Engagement in Latine Patients With Hidradenitis Suppurativa.

Health System Experiences and Care Engagement in Latine Patients With Hidradenitis Suppurativa.

Journal: JAMA dermatology

Published: December 23, 2025

Global barriers to sexual health, pregnancy, and breastfeeding in hidradenitis suppurativa.

Global barriers to sexual health, pregnancy, and breastfeeding in hidradenitis suppurativa.

Journal: International journal of women's dermatology

Published: October 16, 2025

Hidradenitis suppurativa: Intentional efforts to unravel precise mechanisms.

Hidradenitis suppurativa: Intentional efforts to unravel precise mechanisms.

Journal: The Journal of investigative dermatology

Published: October 15, 2025

Long-term efficacy of biologics in moderate-to-severe hidradenitis suppurativa: A systematic review and MAIC.

Long-term efficacy of biologics in moderate-to-severe hidradenitis suppurativa: A systematic review and MAIC.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 02, 2025

Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment.

Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment.

Journal: American journal of clinical dermatology

Published: September 26, 2025

Prevalence of Hidradenitis Suppurativa: A Meta-Analysis of Global Hidradenitis Suppurativa Atlas Studies.

Prevalence of Hidradenitis Suppurativa: A Meta-Analysis of Global Hidradenitis Suppurativa Atlas Studies.

Journal: JAMA dermatology

Published: August 27, 2025

Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension.

Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension.

Journal: Journal of the American Academy of Dermatology

Published: August 20, 2025

Evaluating the diagnostic accuracy of a screening questionnaire for detecting hidradenitis suppurativa: a pooled analysis of accuracy measures from the Global Hidradenitis Suppurativa Atlas (GHiSA) study.

Evaluating the diagnostic accuracy of a screening questionnaire for detecting hidradenitis suppurativa: a pooled analysis of accuracy measures from the Global Hidradenitis Suppurativa Atlas (GHiSA) study.

Journal: The British journal of dermatology

Published: July 17, 2025

Showing 1-12 of 124

Last Updated: 09/26/2026